A novel chimeric coronavirus spike vaccine combining SARS-CoV-2 RBD and scaffold domains from HKU-1 elicits potent neutralising antibody responses

Author(s):

Veronica P. Zoest, Wen Shi Lee, Lydia Murdiyarso, Lauren Burmas, Phillip Pymm, Robyn Esterbauer, Andrew Kelly, Hannah G. Kelly, Isaac Barber-Axthelm, James P. Cooney, Kathryn C. Davidson, Merle Dayton, Courtney E. McAleese, Marianne Gillard, Karen Hughes, Martina L. Jones, Marc Pellegrini, Wai Hong Tham, Ben Hughes, Stephen J. Kent, Adam K. Wheatley, Jennifer A. Juno, Hyon Xhi Tan

Details:

npj Vaccines, Volume 10, Issue 1, 2025-12-01, Article number 275

Article Link: Click here

Affiliations:

• University of Washington
• University of Melbourne
• The University of Sydney
• The University of Queensland
• Monash University
• Walter and Eliza Hall Institute of Medical Research
• ANU Research School of Biology
• The John Curtin School of Medical Research
• Department of Microbiology & Immunology
• Therapeutic Innovation Australia